IMARC Group, a leading market research company, has recently releases report titled “Cell Separation Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cell separation technologies market report, share, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Cell Separation Technologies Market?
The global cell separation technologies market size reached US$ 9.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.2 Billion by 2028, exhibiting a growth rate (CAGR) of 15.6% during 2023-2028.
What is Cell Separation Technologies?
Cell separation technologies, also known as cell sorting or cell isolation, use physical properties to identify and isolate cells from a heterogeneous mixture. Some of the common techniques used for cell separation include density gradient centrifugation, field flow fractionation (FFF), immunogenicity cell isolation, magnet-activated cell sorting (MACS), Immunomagnetic cell separation, buoyancy-activated cell sorting (BACS), fluorescence-activated cell sorting (FACS), and microfluidic cell sorting. These techniques are widely deployed based on varying shapes, densities, sizes, and surface protein expression of the cells to deal with various chronic diseases, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis. As a result, cell separation technologies are widely adopted in hospitals, research laboratories and institutions, cell banks, and biotechnology and biopharmaceutical companies.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/cell-separation-technologies-market/requestsample
What are the growth prospects and trends in the cell separation technologies industry?
The market is primarily driven by the growing incidences of chronic diseases such as cancer, especially among the geriatric population. In addition, the widespread adoption of cell separation technologies in the pharmaceutical sector to enhance drug discovery processes and develop drugs with improved effectiveness is contributing to market growth.
Moreover, the increasing application of cell separation techniques to produce biologics, including recombinant proteins and monoclonal antibodies, and the rising focus on personalized medicines for the selection of appropriate treatment and early detection of disease represent other major growth-inducing factors. Besides this, various initiatives undertaken by government authorities to strengthen the healthcare industry by improving the focus on cell-based research, which is providing a positive thrust to market growth.
Furthermore, rapid expansion in the pharmaceutical and biotechnology industry, the increasing requirement for personalized medicines, and extensive research and development (RD) activities to develop novel vaccines and testing kits are also creating a favorable market outlook.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Instruments
- Consumables
Breakup by Cell Type:
- Human Cells
- Animal Cells
Breakup by Technology:
- Centrifugation-based Cell Separation
- Surface marker-based Cell Separation
- Filtration-based Cell Separation
Breakup by Application:
- Oncology Research
- Neuroscience Research
- Stem Cell Research
- Microbiology
- Immunology Research
- Others
Breakup by End User:
- Research Laboratories and Institute
- Biotechnology and Biopharmaceutical Companies
- Cell Banks
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschränkt) Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
